Thursday, 28 May 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 28 May 2026
Vivacity
Vivacity
Drug class doubles in one month

A new TGA approval has seen the number of drugs in this class double in just one month and it also marks the first Australian regulatory greenlight for a Beijing-headquartered pharma.

$17.7B bid to take pharma private
A private equity firm and Belgian investment group have launched a $17.7 billion bid to take this pharmaceutical company private
TODAY
Why Drs are losing trust in pharma
Uncoordinated messaging can leave HCPs with a low opinion of pharmas even when individual teams are successful
TODAY
TGA teases four drug approvals
Four companies could be on the cusp of having their drugs approved by the TGA and at least one is a potential blockbuster
27 May
Exec exits with pointed sign-off
After 19 years with the same company this Sydney-based leader has left his role with the final word about 'organisational decisions'
27 May
Drug pulled after viability review
Pharma to discontinue supply after assessing the commercial viability of its products and a review of future market demand and product volumes
27 May
Oncology dethroned as No 1
Oncology is no longer the largest contributor to late-stage pipeline value, increasing exposure to therapeutic area-specific shocks
26 May
Probiotec
Probiotec
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (18)

Clinical & Medical, R&D (5)

Regulatory, Pharmacovigilance & QA (3)

Executive Roles (4)

Other (7)

Senior exec leaves pharma
New job, new industry plus the other employment moves across industry, including a farewell after 26 years
TODAY
Lilly muscles into vaccine market
Obesity giant puts $5 billion-plud on the table for next-gen technologies that target diseases with no approved rivals
TODAY
Partnership boosts clinical trials
ARCS is levelling the playing field, launching a partnership to elevate professional development for public clinical research sites
27 May
Sanofi ends 100-year drought
TGA approval marks the biggest development in the field in more than a century, with the company actively pursuing reimbursement
27 May
Gladys takes health sector role
Former NSW Premier said leading the State through the pandemic had taught her the importance of preparedness and treatment
26 May
Seqirus scores vax funding win
Among other changes, a NZ proposal expands flu vaccine coverage to include kids for the first time, tapping CSL for the treatment
26 May
Ex-Aussie Country Boss collects prize
This pharma has been crowned Green Business of the Year, highlighting the company's efforts to align commercial goals with environmental targets
26 May
Who's facing $13.3M in legal costs?
A deal that went sour is far from over with one pharma ordered to pay its rival's hefty legal bill which it described as 'Rolls Royce'
26 May
Country Leader back after Gap Year
After more than 23 years at J&J followed by a year off for travel, time with family and getting fit, this boss is back in a new top role
25 May
Dark Horse climbs Innovation Index
This company has skyrocketed up the leadership board in just 12 months to secure the third position on the 2026 Innovation Index
25 May
Merck backs STEM scholars
Two university students have been named as the first recipients of the Merck Indigenous STEM Leadership Scholarships
25 May
Next-gen drug beats expectations
Latest trial data reveal weight loss results that blow current drugs out of the running, and puts this pharma firmly in pole position
25 May
'Next big thing' wins TGA tick
The TGA has approved two Sanofi drugs including the next big play in diabetes and the first BTK inhibitor for certain patients with MS
25 May Approvals Action
Who's ready for a June PBS listing?
A handful of drugs have jumped up the PBS wait queue, with seven drugs sitting in the last stage before listing occurs
22 May
PiF advertise
PiF advertise
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.